$DOMH
Dominari Holdings Inc. Stock $domh

$domh Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000121390024028218 Filed on April 01, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$1.367M	$1.005M	$2.039M
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$4.172M	$6.858M	$23.84M
YoY Change	8.84%	119.81%	104.04%
% of Gross Profit
Research & Development		-$6.000K	-$3.000K
YoY Change		-120.0%	-100.36%
% of Gross Profit
Depreciation & Amortization	$26.00K	$23.00K	$83.00K
YoY Change	271.43%
% of Gross Profit
Operating Expenses	$4.172M	$6.852M	$23.84M
YoY Change	8.82%	118.22%	66.14%
Operating Profit	-$2.805M		-$21.80M
YoY Change	-26.84%		51.93%
Interest Expense	-$1.721M	$1.931M	$2.126M
YoY Change	-2558.57%	-146.98%	-127.15%
% of Operating Profit
Other Income/Expense, Net	-$2.636M	-$3.000M	-$3.212M
YoY Change	-3761.11%		-58.61%
Pretax Income	-$5.441M	-$6.916M	-$22.88M
YoY Change	44.71%	-4.74%	3.49%
Income Tax
% Of Pretax Income
Net Earnings	-$5.441M	-$6.916M	-$22.88M
YoY Change	44.63%	-4.74%	3.51%
Net Earnings / Revenue	-398.02%	-688.16%	-1122.22%
Basic Earnings Per Share	-$0.91		-$4.38
Diluted Earnings Per Share	-$0.91	-$1.27	-$4.38
COMMON SHARES
Basic Shares Outstanding	5.935M shares	5.345M shares	5.229M shares
Diluted Shares Outstanding	5.995M shares		5.229M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$7.079M	$16.38M	$16.38M
YoY Change	-79.13%	-59.36%	-61.28%
Cash & Equivalents	$1.956M	$2.833M
Short-Term Investments	$5.123M	$13.55M	$13.55M
Other Short-Term Assets	$16.32M	$8.585M	$8.585M
YoY Change	279.63%	853.89%	853.89%
Inventory
Prepaid Expenses
Receivables	$1.955M	$3.177M	$3.177M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$25.36M	$28.14M	$28.14M
YoY Change	-43.36%	-44.44%	-44.49%
LONG-TERM ASSETS
Property, Plant & Equipment	$317.0K	$3.679M	$3.679M
YoY Change	-10.2%		308.78%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$21.69M	$24.15M	$24.15M
YoY Change	-6.1%	4.55%	4.55%
Other Assets	$458.0K	$458.0K	$458.0K
YoY Change	-8.4%	-8.4%	-8.4%
Total Long-Term Assets	$26.84M	$29.42M	$29.42M
YoY Change	-8.67%	15.0%	15.36%
TOTAL ASSETS
Total Short-Term Assets	$25.36M	$28.14M	$28.14M
Total Long-Term Assets	$26.84M	$29.42M	$29.42M
Total Assets	$52.19M	$57.56M	$57.56M
YoY Change	-29.61%	-24.5%	-24.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$840.0K	$1.036M	$1.036M
YoY Change	40.0%	159.0%	159.0%
Accrued Expenses	$714.0K	$549.0K	$549.0K
YoY Change	-28.6%	-57.77%	-57.77%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.596M	$1.607M	$1.607M
YoY Change	-7.21%	-10.17%	-10.72%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$2.929M	$3.028M	$3.028M
YoY Change	-13.85%	332.57%	332.57%
Total Long-Term Liabilities	$2.929M	$3.028M	$3.028M
YoY Change	-13.85%	332.57%	332.57%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.596M	$1.607M	$1.607M
Total Long-Term Liabilities	$2.929M	$3.028M	$3.028M
Total Liabilities	$4.525M	$4.635M	$4.635M
YoY Change	-10.98%	87.73%	85.4%
SHAREHOLDERS EQUITY
Retained Earnings	-$214.2M	-$208.8M
YoY Change	12.95%	12.31%
Common Stock	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$501.0K	$501.0K
YoY Change	0.0%	-84.92%
Treasury Stock Shares
Shareholders Equity	$47.67M	$52.92M	$52.92M
YoY Change
Total Liabilities & Shareholders Equity	$52.19M	$57.56M	$57.56M
YoY Change	-29.61%	-24.5%	-24.46%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$5.441M	-$6.916M	-$22.88M
YoY Change	44.63%	-4.74%	3.51%
Depreciation, Depletion And Amortization	$26.00K	$23.00K	$83.00K
YoY Change	271.43%
Cash From Operating Activities	-$8.594M	-$4.742M	-$22.23M
YoY Change	115.33%	154.95%	109.8%
INVESTING ACTIVITIES
Capital Expenditures		$7.000K	$427.0K
YoY Change		-99.46%	-76.67%
Acquisitions
YoY Change
Other Investing Activities	$7.717M	$3.197M	-$6.743M
YoY Change	-142.05%	20.19%	-47.2%
Cash From Investing Activities	$7.717M	$3.190M	-$7.170M
YoY Change	-141.24%	134.56%	-50.88%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			-$939.0K
YoY Change			-130.71%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		1.000K	-939.0K
YoY Change		-100.12%	-86.95%
NET CHANGE
Cash From Operating Activities	-$8.594M	-4.742M	-22.23M
Cash From Investing Activities	$7.717M	3.190M	-7.170M
Cash From Financing Activities		1.000K	-939.0K
Net Change In Cash	-$877.0K	-1.551M	-30.34M
YoY Change	-96.29%	17.5%	-6.32%
FREE CASH FLOW
Cash From Operating Activities	-$8.594M	-$4.742M	-$22.23M
Capital Expenditures		$7.000K	$427.0K
Free Cash Flow	-$8.594M	-$4.749M	-$22.66M
YoY Change	97.52%	50.28%	82.34%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.95
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.91
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue		usd
CY2022	us-gaap	Revenues Revenues		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-41845
CY2023	dei	Entity Registrant Name EntityRegistrantName	DOMINARI HOLDINGS INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	52-0849320
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	725 5th Avenue
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	22nd Floor
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10022
CY2023	dei	City Area Code CityAreaCode	(212)
CY2023	dei	Local Phone Number LocalPhoneNumber	393-4540
CY2023	dei	Security12b Title Security12bTitle	Common Stock ($0.0001 par value per share)
CY2023	dei	Trading Symbol TradingSymbol	DOMH
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	12149343	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5934917	shares
CY2023	dei	Auditor Firm AuditorFirmId	688
CY2023	dei	Auditor Name AuditorName	Marcum llp
CY2023	dei	Auditor Location AuditorLocation	New York, NY
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2833000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33174000	usd
CY2023Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	13547000	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	7130000	usd
CY2023Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	7687000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	898000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	564000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	301000	usd
CY2022Q4	us-gaap	Other Short Term Investments OtherShortTermInvestments	13000	usd
CY2023Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	3177000	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	7474000	usd
CY2022Q4	domh	Investment In Field Point Securitie InvestmentInFieldPointSecuritie	2000000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	28142000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	50656000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	344000	usd
CY2023Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	1129000	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	1100000	usd
CY2023Q4	us-gaap	Long Term Investments LongTermInvestments	24150000	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	23103000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3335000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	919000	usd
CY2023Q4	us-gaap	Security Deposit SecurityDeposit	458000	usd
CY2022Q4	us-gaap	Security Deposit SecurityDeposit	458000	usd
CY2023Q4	us-gaap	Assets Assets	57558000	usd
CY2022Q4	us-gaap	Assets Assets	76236000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1036000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	447000	usd
CY2023Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	51000	usd
CY2022Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	1260000	usd
CY2023Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	77000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	421000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	82000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	22000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1607000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1789000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3028000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	680000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	4635000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	2469000	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5995065	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5485096	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5934917	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5017079	shares
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	262187000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	262970000	usd
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	60148	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	468017	shares
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	501000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	3322000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-208763000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-185881000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	52923000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	73767000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	57558000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	76236000	usd
CY2023	us-gaap	Revenues Revenues	2039000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	23838000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11683000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	830000	usd
CY2023	domh	Research And Development License Acquired ResearchAndDevelopmentLicenseAcquired	-6000	usd
CY2022	domh	Research And Development License Acquired ResearchAndDevelopmentLicenseAcquired	1833000	usd
CY2023	domh	Less Deposit Previously Transferred In October2022 To Fps LessDepositPreviouslyTransferredInOctober2022ToFPS	2000000	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	1112000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	23835000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	14346000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-21796000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-14346000	usd
CY2023	us-gaap	Other Income OtherIncome	36000	usd
CY2022	us-gaap	Other Income OtherIncome	64000	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	716000	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	687000	usd
CY2023	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	630000	usd
CY2022	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-5952000	usd
CY2023	us-gaap	Gain Loss On Sale Of Notes Receivable GainLossOnSaleOfNotesReceivable	-3248000	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-780000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	2560000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1086000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-7761000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-22882000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-22107000	usd
CY2022	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	4109000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-22882000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-26216000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.38
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.91
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5229477	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5334075	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	101595000	usd
CY2022	domh	Deemed Dividends Related To Series O And Series P Redeemable Convertible Preferred Stock DeemedDividendsRelatedToSeriesOAndSeriesPRedeemableConvertiblePreferredStock	-4109000	usd
CY2022	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	3058000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1472000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Stock Split AdjustmentsToAdditionalPaidInCapitalStockSplit	26000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-22107000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	73767000	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2977000	usd
CY2023	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	939000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-22882000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	52923000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-22882000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-22107000	usd
CY2023	domh	Amortization Of Rightofuse Assets AmortizationOfRightofuseAssets	359000	usd
CY2022	domh	Amortization Of Rightofuse Assets AmortizationOfRightofuseAssets	-188000	usd
CY2023	us-gaap	Depreciation Depreciation	83000	usd
CY2023	domh	Change In Fair Value Of Shortterm Investment ChangeInFairValueOfShorttermInvestment	13000	usd
CY2022	domh	Change In Fair Value Of Shortterm Investment ChangeInFairValueOfShorttermInvestment	2621000	usd
CY2023	domh	Change In Fair Value Of Longterm Investment ChangeInFairValueOfLongtermInvestment	-793000	usd
CY2022	domh	Change In Fair Value Of Longterm Investment ChangeInFairValueOfLongtermInvestment	-61000	usd
CY2022	domh	Research And Developmentacquired License Expense ResearchAndDevelopmentacquiredLicenseExpense	1833000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	2977000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1472000	usd
CY2023	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	-1180000	usd
CY2022	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	-1405000	usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1049000	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-4867000	usd
CY2023	us-gaap	Gain Loss On Sale Of Notes Receivable GainLossOnSaleOfNotesReceivable	-3248000	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	36000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	406000	usd
CY2022Q4	domh	Investments Company Fee Paid Indirectly InvestmentsCompanyFeePaidIndirectly	2000000	usd
CY2023	us-gaap	Investment Company Fee Paid Indirectly InvestmentCompanyFeePaidIndirectly	1400000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	215000	usd
CY2023	domh	Increase Decrease In Prepaid Acquisition Cost IncreaseDecreaseInPrepaidAcquisitionCost	-301000	usd
CY2022	domh	Increase Decrease In Prepaid Acquisition Cost IncreaseDecreaseInPrepaidAcquisitionCost	301000	usd
CY2023	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	4137000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	376000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	66000	usd
CY2023	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-1209000	usd
CY2022	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	580000	usd
CY2023	domh	Increase Decrease In Accrued Commissions IncreaseDecreaseInAccruedCommissions	52000	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-88000	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	31000	usd
CY2023	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-99000	usd
CY2023	us-gaap	Increase Decrease In Notes Receivables IncreaseDecreaseInNotesReceivables	122000	usd
CY2022	us-gaap	Increase Decrease In Notes Receivables IncreaseDecreaseInNotesReceivables	600000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-22232000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10597000	usd
CY2022	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	2000000	usd
CY2023	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	34125000	usd
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	26798000	usd
CY2023	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	27574000	usd
CY2022	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	28658000	usd
CY2022	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	93000	usd
CY2023	domh	Payments To Acquire Tangible Assets PaymentsToAcquireTangibleAssets	427000	usd
CY2023	domh	Acquisition Of Fps Net Of Cash Acquired And Receivable Owed From Fps AcquisitionOfFPSNetOfCashAcquiredAndReceivableOwedFromFPS	1112000	usd
CY2022	domh	Return Of Depositfunding Of Deposit Into A Managed Account Net ReturnOfDepositfundingOfDepositIntoAManagedAccountNet	-3898000	usd
CY2023	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	1102000	usd
CY2023	domh	Payments To Employee Forgivable Loan PaymentsToEmployeeForgivableLoan	107000	usd
CY2022	us-gaap	Payments To Acquire In Process Research And Development PaymentsToAcquireInProcessResearchAndDevelopment	1833000	usd
CY2023	domh	Purchaseofshort Termandlong Terminvestments Purchaseofshort-termandlong-terminvestments	75000	usd
CY2022	domh	Purchaseofshort Termandlong Terminvestments Purchaseofshort-termandlong-terminvestments	15016000	usd
CY2022	domh	Purchase Of Shortterm And Longterm Promissory Notes PurchaseOfShorttermAndLongtermPromissoryNotes	1600000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7170000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-14598000	usd
CY2022	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	17891000	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	26000	usd
CY2022	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	-22000000	usd
CY2023	domh	Payments For Purchase Of Treasury Stock PaymentsForPurchaseOfTreasuryStock	939000	usd
CY2022	domh	Payments For Purchase Of Treasury Stock PaymentsForPurchaseOfTreasuryStock	3058000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-939000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-7193000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-30341000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-32388000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	33174000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	65562000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2833000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	33174000	usd
CY2023	us-gaap	Interest Paid InterestPaid	686000	usd
CY2023	domh	Receiving Shares In Exchange Of Note Receivable Extension ReceivingSharesInExchangeOfNoteReceivableExtension	179000	usd
CY2023	domh	Note Receivable Principal And Interest Receivable Reduced Due To Receiving Shares NoteReceivablePrincipalAndInterestReceivableReducedDueToReceivingShares	143000	usd
CY2022	domh	Transfer From Shortterm Investment To Marketable Securities TransferFromShorttermInvestmentToMarketableSecurities	1497000	usd
CY2022	domh	Reclassify From Convertible Note Receivable To Notes Receivable At Fair Value ReclassifyFromConvertibleNoteReceivableToNotesReceivableAtFairValue	2147000	usd
CY2022	domh	Transfer From Longterm Investment To Marketable Securites TransferFromLongtermInvestmentToMarketableSecurites	1439000	usd
CY2022	domh	Promissory Convertible Note Receivable Conversion Into Common Shares PromissoryConvertibleNoteReceivableConversionIntoCommonShares	899000	usd
CY2023	us-gaap	Stock Issued1 StockIssued1	3112000	usd
CY2023	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	On June 7, 2022, the Company effected a seventeen-for-one (17-for-1) reverse stock split of its class of common stock (the “Reverse Stock Split”).
CY2023	us-gaap	Adjustments To Additional Paid In Capital Stock Split AdjustmentsToAdditionalPaidInCapitalStockSplit	26000000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Use of Estimates</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements have been prepared in conformity with U.S. GAAP. This requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the period. The Company’s significant estimates and assumptions include stock-based compensation, the valuation of investments, the valuation of notes receivable and the valuation allowance related to the Company’s deferred tax assets. Certain of the Company’s estimates could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates and assumptions.</span></p>
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Concentration of Cash</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains cash balances at four financial institutions in checking accounts. From time to time, the Company’s cash account balances exceed the balances as covered by the Federal Deposit Insurance System. The Company has never suffered a loss due to such excess balances. As of December 31, 2023 and 2022, the Company had no cash equivalents.</span></p>
CY2023	domh	Accounting For Warrantstext Block AccountingForWarrantstextBlock	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounting for Warrants</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for the issuance of common stock purchase warrants issued in connection with the equity offerings in accordance with the provisions of Accounting Standards Codification (“ASC”) 815, <i>Derivatives and Hedging</i> (“ASC 815”). The Company classifies as equity any contracts that (i) require physical settlement or net-share settlement or (ii) gives the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement).</span></p>
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P10Y
CY2023Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	6700000	usd
CY2023	domh	Tax Benifit Percentage TaxBenifitPercentage	0.50	pure
CY2023	domh	Change In Fair Value Of Longterm Investments ChangeInFairValueOfLongtermInvestments	793000	usd
CY2023Q4	us-gaap	Long Term Investments LongTermInvestments	24150000	usd
CY2023	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	3400000	usd
CY2023	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	1180000	usd
CY2022	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	1405000	usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1049000	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-4867000	usd
CY2023	us-gaap	Investment Income Dividend InvestmentIncomeDividend	762000	usd
CY2022	us-gaap	Investment Income Dividend InvestmentIncomeDividend	320000	usd
CY2023	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	630000	usd
CY2022	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-5952000	usd
CY2022Q4	us-gaap	Other Short Term Investments OtherShortTermInvestments	13000	usd
CY2023	domh	Receiving Shares In Exchange Of Note Receivable Extensions ReceivingSharesInExchangeOfNoteReceivableExtensions	179000	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	13000	usd
CY2023	us-gaap	Interest Income Short Term Investment Increase Decrease InterestIncomeShortTermInvestmentIncreaseDecrease	13000	usd
CY2022Q4	us-gaap	Other Short Term Investments OtherShortTermInvestments	13000	usd
CY2023	domh	Change In Fair Value Of Shortterm Investment ChangeInFairValueOfShorttermInvestment	13000	usd
CY2023Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	20922000	usd
CY2023Q4	us-gaap	Long Term Investments LongTermInvestments	24150000	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	23103000	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	23103000	usd
CY2023	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	75000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P7Y
CY2023Q1	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	12874	usd
CY2023	us-gaap	Increase Decrease In Prepaid Rent IncreaseDecreaseInPrepaidRent	13502	usd
CY2022Q4	us-gaap	Notes Receivable Fair Value Disclosure NotesReceivableFairValueDisclosure	7474000	usd
CY2023Q4	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	250000	usd
CY2022Q4	us-gaap	Interest Receivable InterestReceivable	200000	usd
CY2023	domh	Repayment Of Interest Receivable RepaymentOfInterestReceivable	300000	usd
CY2022	domh	Repayment Of Interest Receivable RepaymentOfInterestReceivable	0	usd
CY2022	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	0	usd
CY2023Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	13547000	usd
CY2023Q4	us-gaap	Marketable Securities MarketableSecurities	13547000	usd
CY2023Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	3177000	usd
CY2023Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	1129000	usd
CY2022Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	7130000	usd
CY2022Q4	us-gaap	Marketable Securities MarketableSecurities	7130000	usd
CY2022Q4	us-gaap	Other Short Term Investments OtherShortTermInvestments	13000	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	7474000	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	1100000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	427000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	83000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	344000	usd
CY2023	us-gaap	Depreciation Depreciation	83000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P7Y
CY2022Q3	us-gaap	Accrued Rent Current And Noncurrent AccruedRentCurrentAndNoncurrent	49368	usd
CY2022Q3	us-gaap	Increase Decrease In Prepaid Rent IncreaseDecreaseInPrepaidRent	51868	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3335000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	919000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	421000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	82000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3028000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	680000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	3449000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	762000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y6M
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y1M6D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10	pure
CY2023	us-gaap	Lease Cost LeaseCost	800000	usd
CY2022	us-gaap	Lease Cost LeaseCost	100000	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	668000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	73000	usd
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	668000	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	73000	usd
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	105000	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	67000	usd
CY2023	us-gaap	Lease Cost LeaseCost	773000	usd
CY2022	us-gaap	Lease Cost LeaseCost	140000	usd
CY2023Q4	us-gaap	Restricted Cash And Investments RestrictedCashAndInvestments	21000000	usd
CY2023	domh	Aggregate Cash Fee Percentage AggregateCashFeePercentage	0.08	pure
CY2023Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	103528	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	21.25
CY2023	us-gaap	Debt Instrument Redemption Price Percentage DebtInstrumentRedemptionPricePercentage	1.05	pure
	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	1000	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	396000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	231000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2780000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	960000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P5Y
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	747000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	685000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	685000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	685000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	766000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	1160000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4728000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1279000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	3449000	usd
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1001307	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	499552	shares
CY2023Q2	us-gaap	Debt Default Longterm Debt Amount DebtDefaultLongtermDebtAmount	23100000	usd
CY2023	us-gaap	Dividends Dividends	0	usd
CY2022	us-gaap	Dividends Dividends	4100000	usd
CY2023Q1	domh	Shares Cancelled SharesCancelled	644499	shares
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	644499	shares
CY2023Q1	domh	Shares Cancelled SharesCancelled	25000	shares
CY2022Q1	us-gaap	Program Rights Obligations ProgramRightsObligations	3000000	usd
CY2023Q1	us-gaap	Treasury Stock Shares Retired TreasuryStockSharesRetired	644499	shares
CY2023Q1	us-gaap	Treasury Stock Retired Cost Method Amount TreasuryStockRetiredCostMethodAmount	3800000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	238244	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.13
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	230176	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	6.14
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	8068	shares
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	5.9
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	1315777	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.27
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	1187536	shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	2.3
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	136309	shares
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	2.26
CY2023	us-gaap	Restricted Stock Expense RestrictedStockExpense	2700000	usd
CY2022	us-gaap	Restricted Stock Expense RestrictedStockExpense	1400000	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	200000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	28203	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	548.35
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y2M12D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	170587	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.95
CY2022	domh	Employee Options Granted Weighted Average Remaining Contractual Lifein Years EmployeeOptionsGrantedWeightedAverageRemainingContractualLifeinYears	P0Y3M18D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	167381	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	41.9
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	216	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	73.7
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	31193	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	302.97
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y10M24D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	395714	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.42
CY2023	domh	Employee Options Granted Weighted Average Remaining Contractual Lifein Years EmployeeOptionsGrantedWeightedAverageRemainingContractualLifeinYears	P9Y4M24D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	5882	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	5.95
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	857	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	9719.07
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	420168	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.8
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y3M18D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	84929	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	15.16
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P8Y9M18D
CY2023	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	500000	usd
CY2023	us-gaap	Underwriting Income Loss UnderwritingIncomeLoss	594000	usd
CY2023	us-gaap	Brokerage Commissions Revenue BrokerageCommissionsRevenue	1096000	usd
CY2023	us-gaap	Payments For Merger Related Costs PaymentsForMergerRelatedCosts	209000	usd
CY2023	us-gaap	Noninterest Income Other NoninterestIncomeOther	140000	usd
CY2023	us-gaap	Revenues Revenues	2039000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	3820000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	3618000	usd
CY2023	domh	Increase Decrease In Valuation Allowance Federal IncreaseDecreaseInValuationAllowanceFederal	3820000	usd
CY2022	domh	Increase Decrease In Valuation Allowance Federal IncreaseDecreaseInValuationAllowanceFederal	3618000	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	3012000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	4825000	usd
CY2023	domh	Increase In Valuation Allowance State And Local IncreaseInValuationAllowanceStateAndLocal	3012000	usd
CY2022	domh	Increase In Valuation Allowance State And Local IncreaseInValuationAllowanceStateAndLocal	4825000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.1536	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.1358	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.0054	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.0011	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.0418	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.0295	pure
CY2023	domh	Effective Income Tax Rate Reconciliation Decrease Due To True Up Of State Nol EffectiveIncomeTaxRateReconciliationDecreaseDueToTrueUpOfStateNOL	-0.0011	pure
CY2022	domh	Effective Income Tax Rate Reconciliation Decrease Due To True Up Of State Nol EffectiveIncomeTaxRateReconciliationDecreaseDueToTrueUpOfStateNOL	0.0069	pure
CY2023	domh	Effective Income Tax Rate Reconciliation Decrease Due To Change In Federal Nol And Other True Ups EffectiveIncomeTaxRateReconciliationDecreaseDueToChangeInFederalNOLAndOtherTrueUps	-0.0167	pure
CY2022	domh	Effective Income Tax Rate Reconciliation Decrease Due To Change In Federal Nol And Other True Ups EffectiveIncomeTaxRateReconciliationDecreaseDueToChangeInFederalNOLAndOtherTrueUps	0.0004	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.2985	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.3815	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	33124000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	26241000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	9754000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	8358000	usd
CY2023Q4	domh	Deferred Tax Assets Tax Patents And Licenses DeferredTaxAssetsTaxPatentsAndLicenses	8061000	usd
CY2022Q4	domh	Deferred Tax Assets Tax Patents And Licenses DeferredTaxAssetsTaxPatentsAndLicenses	9898000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Hedging Transactions DeferredTaxAssetsHedgingTransactions	209000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Hedging Transactions DeferredTaxAssetsHedgingTransactions	23000	usd
CY2023Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	1937000	usd
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	2207000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	1202000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	272000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	2879000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	2445000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	57166000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	49443000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	55946000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	49115000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1220000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	328000	usd
CY2023Q4	domh	Deferred Tax Liability Depreciation DeferredTaxLiabilityDepreciation	57000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Regulatory Assets And Liabilities DeferredTaxLiabilitiesRegulatoryAssetsAndLiabilities	1163000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Regulatory Assets And Liabilities DeferredTaxLiabilitiesRegulatoryAssetsAndLiabilities	328000	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	6800000	usd
CY2023	domh	Deferred Tax Assets Net Operating Loss Carry Forwards Federal DeferredTaxAssetsNetOperatingLossCarryForwardsFederal	40700000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	152300000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Other DeferredTaxAssetsTaxCreditCarryforwardsOther	200000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Investment EffectiveIncomeTaxRateReconciliationTaxCreditsInvestment	0.50	pure
CY2023Q4	us-gaap	Excess Capital ExcessCapital	4700000	usd
CY2023Q4	us-gaap	Capital Units Net Amount CapitalUnitsNetAmount	200000	usd
CY2023	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	75000	usd
CY2022	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	1000000	usd
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent		usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent		usd
CY2023Q4	us-gaap	Other Short Term Investments OtherShortTermInvestments		usd
CY2023Q4	domh	Investment In Field Point Securitie InvestmentInFieldPointSecuritie		usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet		usd
CY2022Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent		usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent		usd
CY2022	us-gaap	Gain Loss On Sale Of Notes Receivable GainLossOnSaleOfNotesReceivable		usd
CY2023	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments		usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued		usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices		usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther		usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits		usd
CY2022	domh	Redemption Of Series P Redeemable Convertible Preferred Stock RedemptionOfSeriesPRedeemableConvertiblePreferredStock		usd
CY2022	domh	Cancellation Of Common Stock Related To Investment In Cb Min Shares CancellationOfCommonStockRelatedToInvestmentInCBMinShares		usd
CY2023	domh	Cancellation Of Common Stock CancellationOfCommonStock		usd
CY2023	us-gaap	Treasury Stock Retired Par Value Method Amount TreasuryStockRetiredParValueMethodAmount		usd
CY2022	us-gaap	Depreciation Depreciation		usd
CY2023	domh	Research And Developmentacquired License Expense ResearchAndDevelopmentacquiredLicenseExpense		usd
CY2022	us-gaap	Gain Loss On Sale Of Notes Receivable GainLossOnSaleOfNotesReceivable		usd
CY2022	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets		usd
CY2022	domh	Increase Decrease In Accrued Commissions IncreaseDecreaseInAccruedCommissions		usd
CY2022	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities		usd
CY2023	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments		usd
CY2023	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets		usd
CY2022	domh	Payments To Acquire Tangible Assets PaymentsToAcquireTangibleAssets		usd
CY2022	domh	Acquisition Of Fps Net Of Cash Acquired And Receivable Owed From Fps AcquisitionOfFPSNetOfCashAcquiredAndReceivableOwedFromFPS		usd
CY2023	domh	Return Of Depositfunding Of Deposit Into A Managed Account Net ReturnOfDepositfundingOfDepositIntoAManagedAccountNet		usd
CY2022	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable		usd
CY2022	domh	Payments To Employee Forgivable Loan PaymentsToEmployeeForgivableLoan		usd
CY2023	us-gaap	Payments To Acquire In Process Research And Development PaymentsToAcquireInProcessResearchAndDevelopment		usd
CY2023	domh	Purchase Of Shortterm And Longterm Promissory Notes PurchaseOfShorttermAndLongtermPromissoryNotes		usd
CY2023	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock		usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
CY2023	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock		usd
CY2022	us-gaap	Interest Paid InterestPaid		usd
CY2022	domh	Receiving Shares In Exchange Of Note Receivable Extension ReceivingSharesInExchangeOfNoteReceivableExtension		usd
CY2023	domh	Transfer From Shortterm Investment To Marketable Securities TransferFromShorttermInvestmentToMarketableSecurities		usd
CY2023	domh	Reclassify From Convertible Note Receivable To Notes Receivable At Fair Value ReclassifyFromConvertibleNoteReceivableToNotesReceivableAtFairValue		usd
CY2023	domh	Transfer From Longterm Investment To Marketable Securites TransferFromLongtermInvestmentToMarketableSecurites		usd
CY2023	domh	Promissory Convertible Note Receivable Conversion Into Common Shares PromissoryConvertibleNoteReceivableConversionIntoCommonShares		usd
CY2023Q4	us-gaap	Other Short Term Investments OtherShortTermInvestments		usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments		usd
CY2023Q4	us-gaap	Other Short Term Investments OtherShortTermInvestments		usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross		usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment		usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet		usd
CY2022	us-gaap	Depreciation Depreciation		usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber		shares
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2022	domh	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue		usd
CY2022	domh	Share Based Compensation Arrangement By Share Based Payment Award Options Forfieted In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfietedInPeriodIntrinsicValue		usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023	domh	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue		usd
CY2023	domh	Share Based Compensation Arrangement By Share Based Payment Award Options Forfieted In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfietedInPeriodIntrinsicValue		usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue		usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue		usd
CY2022	us-gaap	Underwriting Income Loss UnderwritingIncomeLoss		usd
CY2022	us-gaap	Brokerage Commissions Revenue BrokerageCommissionsRevenue		usd
CY2022	us-gaap	Payments For Merger Related Costs PaymentsForMergerRelatedCosts		usd
CY2022	us-gaap	Noninterest Income Other NoninterestIncomeOther		usd
CY2022	us-gaap	Revenues Revenues		usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2023	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit		usd
CY2022	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Other EffectiveIncomeTaxRateReconciliationTaxCreditsOther		pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Other EffectiveIncomeTaxRateReconciliationTaxCreditsOther		pure
CY2022Q4	domh	Deferred Tax Liability Depreciation DeferredTaxLiabilityDepreciation		usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0000012239

Files In Submission

Name	View Source	Status
0001213900-24-028218-index-headers.html	Edgar Link	pending
0001213900-24-028218-index.html	Edgar Link	pending
0001213900-24-028218.txt	Edgar Link	pending
0001213900-24-028218-xbrl.zip	Edgar Link	pending
domh-20231231.xsd	Edgar Link	pending
ea0202511-10k_domin.htm	Edgar Link	pending
ea020251101ex21-1_dominari.htm	Edgar Link	pending
ea020251101ex23-1_dominari.htm	Edgar Link	pending
ea020251101ex31-1_dominari.htm	Edgar Link	pending
ea020251101ex31-2_dominari.htm	Edgar Link	pending
ea020251101ex32-1_dominari.htm	Edgar Link	pending
ea020251101ex32-2_dominari.htm	Edgar Link	pending
ea020251101ex97-1_dominari.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
img_001.jpg	Edgar Link	pending
img_002.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
domh-20231231_cal.xml	Edgar Link	unprocessable
domh-20231231_def.xml	Edgar Link	unprocessable
domh-20231231_lab.xml	Edgar Link	unprocessable
domh-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ea0202511-10k_domin_htm.xml	Edgar Link	completed
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DOMH
Dominari Holdings Inc. Stock $domh

2024 Q1 Form 10-K Financial Statement

#000121390024028218 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DOMH Dominari Holdings Inc. Stock $domh

2024 Q1 Form 10-K Financial Statement

#000121390024028218 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DOMH
Dominari Holdings Inc. Stock $domh